| Structure |
Chemical Name |
CAS |
MF |
 |
PLX4032 |
918504-65-1 |
C23H18ClF2N3O3S |
 |
Pemetrexed Disodium |
150399-23-8 |
C20H22N5NaO6 |
 |
Bortezomib |
179324-69-7 |
C19H25BN4O4 |
 |
Carboplatin |
41575-94-4 |
C6H12N2O4Pt |
 |
Cisplatin |
15663-27-1 |
Cl2H6N2Pt |
 |
Cediranib |
288383-20-0 |
C25H27FN4O3 |
 |
Combretastatin A4 phosphate disodium salt |
168555-66-6 |
C18H19O8P.2Na |
 |
Lenalidomide |
191732-72-6 |
C13H13N3O3 |
 |
Oxaliplatin |
61825-94-3 |
C8H12N2O4Pt |
 |
Mitotan |
53-19-0 |
C14H10Cl4 |
 |
1822357-78-7 |
1822357-78-7 |
|
 |
Linrodostat mesylate |
2221034-29-1 |
C25H28ClFN2O4S |
 |
Pelidotin |
1438849-92-3 |
C68H100N12O14S |
 |
Muparfostat sodium |
1020105-88-7 |
C12H14O35PS7.(C6H7O14S3.3Na)n.9Na |
 |
Tanomastat |
179545-77-8 |
C23H19ClO3S |
![Immunoglobulin, anti-(human glycoprotein NMB extracellular domain) (human monoclonal CR011 heavy chain), disulfide with human monoclonal CR011 κ-chain, dimer, thioether with N-[[[4-[[N-[6-(3-mercapto-2,5-dioxo-1-pyrrolidinyl)-1-oxohexyl]-L-valyl-N5-(aminocarbonyl)-L-ornithyl]amino]phenyl]methoxy]car...](/) |
Immunoglobulin, anti-(human glycoprotein NMB extracellular domain) (human monoclonal CR011 heavy chain), disulfide with human monoclonal CR011 κ-chain, dimer, thioether with N-[[[4-[[N-[6-(3-mercapto-2,5-dioxo-1-pyrrolidinyl)-1-oxohexyl]-L-valyl-N5-(aminocarbonyl)-L-ornithyl]amino]phenyl]methoxy]car... |
1182215-65-1 |
|
 |
RAD51-IN-2 |
2301085-04-9 |
C27H40N4O6S2 |
 |
Yttrium (90Y) Clivatuzumab Tetraxetan |
943976-23-6 |
|
 |
Farletuzumab |
896723-44-7 |
|
 |
Drozitumab |
912628-39-8 |
|
 |
Brontictuzumab |
1447814-75-6 |
|
 |
Vandortuzumab Vedotin |
1471985-92-8 |
|
 |
Zanidatamab |
2169946-15-8 |
|
 |
Cofetuzumab |
1869928-62-0 |
|
 |
Amivantamab |
2171511-58-1 |
|
 |
Axatilimab |
2155851-88-8 |
|
![Pyrazolo[4,3-b]pyrido[4,3-e][1,4]diazepine, 5-(2-chlorophenyl)-1,2-dihydro-3-methyl-8-(4-morpholinyl)-](/CAS/20200611/GIF/2230490-29-4.gif) |
Pyrazolo[4,3-b]pyrido[4,3-e][1,4]diazepine, 5-(2-chlorophenyl)-1,2-dihydro-3-methyl-8-(4-morpholinyl)- |
2230490-29-4 |
C20H19ClN6O |
 |
Carzelesin |
119813-10-4 |
C41H37ClN6O5 |
 |
Livmoniplimab |
2412004-88-5 |
|
 |
Silverfluoroborate |
1404-20-2 |
|
 |
D-Aminolevulinicacidmethylesterhydrochloride |
33320-16-0 |
C6H12ClNO3 |
 |
α-Interferon |
308067-63-2 |
|
 |
Simtrazene |
5579-27-1 |
C14H16N4 |
 |
Linavonkibart |
2640981-30-0 |
|
 |
Research Grade Ipafricept (DHK29201) |
1391727-24-4 |
|
 |
Bocodepsin |
1834513-65-3 |
C26H39N5O6S2 |
 |
Cobomarsensodium |
1848257-85-1 |
|
 |
Oberotatug |
2641919-34-6 |
|
 |
Verzistobart |
2649466-18-0 |
|
 |
/ |
2641651-83-2 |
C24H27Cl2F3N6O.C6H6O3S |
 |
Rosomidnar |
871597-03-4 |
|
 |
ADOZELESIN |
110314-48-2 |
C30H22N4O4 |
 |
Research Grade Onvapegleukin Alfa |
2764760-02-1 |
|
![5-[(2-Aminoethyl)amino]-2-(2-diethylaminoethyl)-2H-[1]benzothiopyrano[4,3,2-cd]indazol-8-ol](/CAS/GIF/119221-49-7.gif) |
5-[(2-Aminoethyl)amino]-2-(2-diethylaminoethyl)-2H-[1]benzothiopyrano[4,3,2-cd]indazol-8-ol |
119221-49-7 |
|
 |
N-(Phosphonoacetyl)-L-aspartic acid 1,4-disodium salt |
66569-27-5 |
C6H8NNa2O8P |
 |
Teroxirone |
59653-73-5 |
C12H15N3O6 |
![Dibenz[cd,g]indazol-6(2H)-one,5-[(3-aminopropyl)amino]-7,10-dihydroxy-2-[2-[(2-hydroxyethyl)amino]ethyl]-,hydrochloride (1:2)](/) |
Dibenz[cd,g]indazol-6(2H)-one,5-[(3-aminopropyl)amino]-7,10-dihydroxy-2-[2-[(2-hydroxyethyl)amino]ethyl]-,hydrochloride (1:2) |
105118-12-5 |
C21H25N5O4.2ClH |
 |
MGA271 |
1353485-38-7 |
|
 |
Tucidinostat (Chidamide) |
1616493-44-7 |
C22H19FN4O2 |
 |
Milademetan |
1398568-47-2 |
C30H34Cl2FN5O4 |
 |
PSMA-617 |
1702967-37-0 |
C49H71N9O16 |
 |
Molibresib besylate |
1895049-20-3 |
C28H28ClN5O5S |
![Sulfamic acid, [(1R,2S,4R)-4-[[5-[[4-[(1R)-7-chloro-1,2,3,4-tetrahydro-1-isoquinolinyl]-5-methyl-2-thienyl]carbonyl]-4-pyrimidinyl]amino]-2-hydroxycyclopentyl]methyl ester](/CAS/20200331/GIF/1858276-04-6.gif) |
Sulfamic acid, [(1R,2S,4R)-4-[[5-[[4-[(1R)-7-chloro-1,2,3,4-tetrahydro-1-isoquinolinyl]-5-methyl-2-thienyl]carbonyl]-4-pyrimidinyl]amino]-2-hydroxycyclopentyl]methyl ester |
1858276-04-6 |
C25H28ClN5O5S2 |
 |
Lorvotuzumab Mertansine |
1008106-64-6 |
|
 |
Verubulin |
827031-83-4 |
C17H17N3O |
 |
ON 013105 |
865784-01-6 |
C19H21Na2O10PS |
 |
8-Chloro-cAMP |
41941-56-4 |
C10H11ClN5O6P |
 |
LyMphoCide |
501423-23-0 |
|
 |
INNO206 |
1361644-26-9 |
C37H42N4O13 |
 |
Icrucumab |
1024603-92-6 |
|
 |
Flanvotumab |
1188277-05-5 |
|
 |
Vorsetuzumab Mafodotin |
1165741-01-4 |
|
 |
Lenzilumab |
1229575-09-0 |
|
 |
Tafasitamab |
1422527-84-1 |
|
 |
Inebilizumab |
1299440-37-1 |
|
 |
Vadastuximab |
1436390-63-4 |
|
 |
Depatuxizumab Mafodotin |
1585973-65-4 |
|
 |
Belantamab |
2061894-48-0 |
|
 |
Cetuximab Sarotalocan |
2166339-33-7 |
|
 |
Epcoritamab |
2134641-34-0 |
|
 |
Tavolimab |
1635395-25-3 |
|
 |
Bisantrene dihydrochloride |
71439-68-4 |
C22H22N8.2(HCl) |
![2H-Pyrimido[4,5-d][1,3]oxazin-2-one, 7-[[(1S)-1-[4-[(1S)-2-cyclopropyl-1-[4-(1-oxo-2-propen-1-yl)-1-piperazinyl]ethyl]phenyl]ethyl]amino]-1-ethyl-1,4-dihydro-](/CAS/20210305/GIF/2230263-60-0.gif) |
2H-Pyrimido[4,5-d][1,3]oxazin-2-one, 7-[[(1S)-1-[4-[(1S)-2-cyclopropyl-1-[4-(1-oxo-2-propen-1-yl)-1-piperazinyl]ethyl]phenyl]ethyl]amino]-1-ethyl-1,4-dihydro- |
2230263-60-0 |
C28H36N6O3 |
 |
Pavurutamab |
2250292-39-6 |
|
 |
Runimotamab |
2361325-98-4 |
|
 |
Mupadolimab |
2451856-97-4 |
|
 |
Tulmimetostat |
2567686-02-4 |
C28H36ClN3O5S |
 |
Etoprine |
18588-57-3 |
C12H12Cl2N4 |
 |
3-(4-(4-aminopiperidin-1-yl)-3-(3,5-difluorophenyl)quinolin-6-yl)-2-hydroxybenzonitrile hydrochloride |
2361216-83-1 |
C27H23ClF2N4O |
 |
Osemitamab |
2460539-61-9 |
|
 |
Forimtamig |
2649379-96-2 |
|
 |
Research Grade Vandortuzumab (DHJ76001) |
1557989-52-2 |
|
 |
Research Grade Visugromab (DHJ48302) |
2556646-63-8 |
|
![Glycinamide, N-[6-[2-(methylsulfonyl)-5-pyrimidinyl]-1-oxo-5-hexyn-1-yl]-L-valyl-N6,N6-dipropyl-L-lysyl-N-[[3-[(7S)-7-ethyl-7,8,11,13-tetrahydro-7-hydroxy-8,11-dioxo-10H-1,3-dioxolo[4,5-g]pyrano[3′,4′:6,7]indolizino[1,2-b]quinolin-14-yl]propoxy]methyl]-](/CAS/20240320/GIF/2821770-49-2.gif) |
Glycinamide, N-[6-[2-(methylsulfonyl)-5-pyrimidinyl]-1-oxo-5-hexyn-1-yl]-L-valyl-N6,N6-dipropyl-L-lysyl-N-[[3-[(7S)-7-ethyl-7,8,11,13-tetrahydro-7-hydroxy-8,11-dioxo-10H-1,3-dioxolo[4,5-g]pyrano[3′,4′:6,7]indolizino[1,2-b]quinolin-14-yl]propoxy]methyl]- |
2821770-49-2 |
C55H71N9O13S |
 |
BMS 181176 |
119673-08-4 |
C33H34Cl2N4O7 |
 |
Olaptesedpegol |
1390628-22-4 |
|
 |
Patritumab deruxtecan |
2227102-46-5 |
|
 |
Datopotamab deruxtecan |
2238831-60-0 |
|
 |
mitogillin |
1403-99-2 |
|
 |
Mitosper |
11056-15-8 |
|
 |
aderbasib |
791828-58-5 |
C21H28N4O5 |
 |
Sivifene |
2675-35-6 |
C19H14N4O6 |
 |
Leurosine Sulfate |
54081-68-4 |
C46H58N4O13S |
 |
MITOCROMIN |
11043-98-4 |
|
 |
Unii-W6E275iurx |
132937-89-4 |
C44H60Cl4N10O9 |
 |
IPI-926 |
1037210-93-7 |
C29H48N2O3S |
 |
Denibulin Hydrochloride |
779356-64-8 |
C18H20ClN5O3S |
 |
Cevipabulin FuMarate |
849550-69-2 |
C22H22ClF5N6O5 |
 |
SN 2310 |
850728-18-6 |
C55H72N2O9 |
 |
PCI-24781 HCL |
783356-67-2 |
C21H24ClN3O5 |